West Pharmaceutical Services
WST
366.48
-6.16
-1.65%
West Pharmaceutical Services
US · WST
#752 by market cap
Listed 1970
366.48
-6.16
-1.65%
Live - 5344 symbols - heartbeat 458s ago
· 2026-10-08 07:35
Pre-market
366.60
+0.03%
After-hours
366.48
0.00%
Overnight
368.00
+0.41%
- Market cap
- 25.79B
- P/E (TTM)i
- 46.92
- P/Bi
- 8.63
- EPSi
- 6.79
- Div yieldi
- 0.24%
- 52W posi
- 88%
Reader sentiment
Are you bullish or bearish on WST?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 10 analysts
Buy
Avg price target
412.11 +12.5%
Price target rangecurrent 366.48
Low390.00
Avg412.11
High447.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-22 | Morgan Stanley | -- | BUY | 400.00 |
| 2026-09-14 | Morgan Stanley | -- | HOLD | 365.00 |
| 2026-09-09 | UBS | -- | BUY | 415.00 |
| 2026-08-03 | Citi | -- | BUY | 412.00 |
| 2026-07-27 | Evercore | -- | BUY | 425.00 |
| 2026-07-24 | BofA Securities | -- | BUY | 410.00 |
| 2026-07-24 | Barclays | -- | BUY | 400.00 |
| 2026-07-23 | TD Cowen | -- | BUY | 410.00 |
| 2026-07-23 | William Blair | -- | BUY | -- |
| 2026-07-23 | Evercore | -- | BUY | 410.00 |
| 2026-07-15 | TD Cowen | -- | BUY | 410.00 |
| 2026-07-13 | BNP Paribas | -- | BUY | 447.00 |
| 2026-07-09 | Morgan Stanley | -- | HOLD | 365.00 |
| 2026-07-06 | Evercore | -- | BUY | 410.00 |
| 2026-07-02 | KeyBanc | -- | BUY | 390.00 |
| 2026-06-09 | Barclays | -- | BUY | 400.00 |
| 2026-06-02 | BofA Securities | -- | BUY | -- |
| 2026-06-01 | Wolfe Research | -- | BUY | 375.00 |
| 2026-05-29 | Morgan Stanley | -- | HOLD | 325.00 |
| 2026-05-28 | Morgan Stanley | -- | HOLD | 325.00 |
| 2026-05-21 | BofA Securities | -- | BUY | -- |
| 2026-05-20 | William Blair | -- | BUY | -- |
| 2026-05-13 | BofA Securities | -- | BUY | -- |
| 2026-05-12 | William Blair | -- | BUY | -- |
| 2026-04-27 | Morgan Stanley | -- | HOLD | 315.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Buy
Analyst consensus
Buy
All 3 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Improving
2
■ Upgrades■ Downgrades
- 2 upgrades vs 0 downgrades among tracked analyst rating changes.
- Most recent: Morgan Stanley moved from Hold to Buy on 2026-09-22.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-22 | Morgan Stanley | HOLD → BUY | 400.00 |
| 2026-06-09 | Barclays | HOLD → BUY | 400.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-23 | -- | ±9.30% | -0.82% (in line) |
| 2026/Q1 | 2026-04-23 | -- | ±10.24% | +12.86% (beat) |
| 2025/Q4 | 2026-02-12 | -- | ±10.29% | -1.04% (in line) |
| 2025/Q3 | 2025-10-23 | -- | ±11.14% | +10.92% (in line) |
| 2025/Q2 | 2025-07-24 | -- | ±12.65% | +22.78% (beat) |
| 2025/Q1 | 2025-04-24 | -- | ±13.68% | -3.48% (in line) |
| 2024/Q4 | 2025-02-13 | -- | ±9.30% | -38.22% (beat) |
| 2024/Q3 | 2024-10-24 | -- | ±11.95% | +15.43% (beat) |
| 2024/Q2 | 2024-07-25 | -- | ±9.48% | -14.40% (beat) |
| 2024/Q1 | 2024-04-25 | -- | ±7.46% | -4.55% (in line) |
| 2023/Q4 | 2024-02-15 | -- | ±6.25% | -14.08% (beat) |
| 2023/Q3 | 2023-10-26 | -- | ±8.21% | -8.57% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:35:06 · For reference only, not investment advice and not tailored to your situation.